The U.S. Food and Drug Administration (FDA) has cleared the XACT ACE robotic system from XACT Robotics for CT-guided percutaneous procedures.
ACE is the company's second-generation system, which is expected to launch later this year with a focus on interventional radiologists.
The system is a hands-free device that allows users to plan and navigate procedures using imaging. Additionally, its remote capabilities allow the system to be used from outside the radiology procedure room, minimizing staff and patient exposure and enhancing safety measures, according to the firm.
